TransMedics Group (TMDX) Plunges Amidst Allegations of Fraud, …
6 days ago · TransMedics’ stock price has dropped $9.84, or 13%, since Scorpion released a report, titled “Walk Like An Egyptian,” leveling serious allegations against the company, including fraud, organ ...
TransMedics Responds to Inaccurate and Misleading Claims in …
Jan 10, 2025 · The report fails to accurately represent TransMedics' business, technology, diverse culture and steadfast focus on delivering exceptional products and services to meet the needs of the global transplant community.
Likely Trend of TMDX Stock Following the News - Yahoo Finance
Jan 20, 2025 · TransMedics Group, Inc. TMDX recently issued a statement refuting the claims made in a report by short-seller Scorpion Capital on Jan. 10, 2025, stating them as inaccurate and misleading. Per the ...
TMDX INVESTIGATION: TransMedics Shares Remain Down
4 days ago · TMDX INVESTIGATION: TransMedics Shares Remain Down Following Report by Scorpion Capital; Investors Encouraged to Contact Block & Leviton to Potentially Recover Losses Provided by GlobeNewswire Jan ...
Why TransMedics Fell 15.7% This Week | The Motley Fool
Jan 17, 2025 · Scorpion attacks. Last Friday, Scorpion Capital published a 342-page short report -- yes, 342 pages! -- detailing an alleged six-month investigation into TransMedics and its business practices.
TransMedics Responds to Inaccurate and Misleading Claims in …
ANDOVER, Mass., Jan. 13, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ...
TransMedics faces fraud, organ trafficking accusations
Jan 16, 2025 · TransMedics (Nasdaq: TMDX) is facing allegations of fraud, organ trafficking, and unethical practices that have triggered shareholder investigations. The claims, detailed in a report by...
TransMedics says claims made by Scorpion Capital ‘have no merit’
Jan 13, 2025 · TransMedics (TMDX) Group addressed what we believe are inaccurate and misleading claims made in a short-seller report issued by Scorpion Capital on January 10.
TransMedics Shares Plunge Following Short Seller Allegations
Jan 10, 2025 · TransMedics Group (NASDAQ:TMDX) experienced a sharp decline in its stock price today, falling over 15% following the release of a critical report by Scorpion Capital.
Scorpion Capital shorts TransMedics, shares down - Yahoo Finance
Jan 10, 2025 · Investing.com -- Short seller Scorpion Capital disclosed a short position in TransMedics Group Inc (NASDAQ:TMDX) accusing the organ transplant tech. company of fraudulent practices, including...